Skip to content

Christopher J. Kennedy, MD

NPI 1487682365ActiveIndividual· Internal Medicine, Cardiovascular Disease· Bristol, TN

Internal Medicine, Cardiovascular Disease (MD) in Bristol, Tennessee, licensed in TN, with an NPI issued in June 2006. Part D covered 190 prescriptions written in 2024, 77% of them generic. Abbott Laboratories reported $345.68 in payments in 2025, mostly food and beverage.

Overview

NPI1487682365
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedJun 29, 2006
Last updated in NPPESDec 3, 2014

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Cardiovascular Disease Primary207RC0000X17737TN

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Cardiovascular Disease (Cardiology) (TN)

Part D prescriptions in 2024

Prescriptions (claims)190 · 390 30-day fills
Patients88
Total drug cost$35,470
Generic share77% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$345.68 · 17 payments from 1 company
  • 2024$582.56 · 30 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Abbott Laboratories$345.6817

What the 2025 payments were for

  • Food and Beverage$345.68 · 17 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Cardiovascular Disease providers in Bristol

All Internal Medicine, Cardiovascular Disease providers in Tennessee →